Clinical Trial Update: Tulip Study: Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether initiating insulin glargine (Lantus) earlier in the treatment of type 2 diabetes provides clinical benefits.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED